Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer
- 1 July 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (10) , 1617-1623
- https://doi.org/10.1016/j.ejca.2004.02.028
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 16 references indexed in Scilit:
- Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell UsJNCI Journal of the National Cancer Institute, 2002
- RECKing MMP function: implications for cancer developmentTrends in Cell Biology, 2002
- The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and AngiogenesisCell, 2001
- Involvement of the Sp1 Site in ras-Mediated Downregulation of the RECK Metastasis Suppressor GeneBiochemical and Biophysical Research Communications, 1999
- Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECKProceedings of the National Academy of Sciences, 1998
- Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer.American Journal of Respiratory and Critical Care Medicine, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989